ARCHIVES

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

This article is from The Cancer Letter archive.

Vol. 25 No. 34 | September 10, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

NCI-Approved Clinical Trials

May 28, 2004

AACR honors Five With Awards Next Month

April 2, 1993